Unique Composition of CNM-Au8 to Treat MS and ALS: Michael Hotchkin
September 24th 2022The chief development officer at Clene Nanomedicine provided insight on why CNM-Au8, an investigational agent in development, has shown positive results across both multiple sclerosis and ALS. [WATCH TIME: 2 minutes]